Prediction of COPD Severity Using Electrical Impedance Tomography
NCT ID: NCT06359145
Last Updated: 2024-04-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
150 participants
OBSERVATIONAL
2023-04-01
2024-08-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Detect and Infer the Severity of COPD by Intelligent Terminal Device
NCT05551169
Analysis With Clusters of QUAntitative Tomodensitometric Vascular, bronchIal and Parenchymal Pulmonary Parameters for COPD Patients
NCT03337854
Artificial Intelligence in Computed Tomography for Quantifying Lung Changes of Bronchiectasis Patients
NCT05751538
Assessment of Lung Movement With Computed Tomography (CT)
NCT03068091
Evidence-based Analysis of Low-dose CT in Management of COPD
NCT02599883
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age \> 20 years, and be able to communicate with doctors.
* Willing to sign informed consent for the course of the study.
Exclusion Criteria
* The CT scan information is incomplete, and the interval between the pulmonary function test and the CT scan is more than 180 days.
20 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chinese PLA General Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
wang kaifei
Director, Department of Respiratory and Critical Care Medicine, Chinese PLA General Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
PLA
Beijing, Beijing Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
EIT and COPD
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.